Additionally, almost 40% of HCC samples have somatic mutations in at least one gene whose product is a member of the TGF-β signaling pathway (Chen et al. 2018; Waddell et al. 2015). The gene discussed is TGFB1; the disease is hepatocellular carcinoma.